{"entity":{"type":"insider","cik":"0001406337","url":"/insider/0001406337","json_url":"/insider/0001406337.json","name":"Graves Kurt","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":17,"first":"2007-11-07","last":"2019-04-18","span_basis":"filed_date"},"name_variants":[{"name":"Graves Kurt","source":"filing","n_filings":17,"first_seen":"2007-11-07","last_seen":"2019-04-18"}],"transactions":[{"id":8645794,"accession":"0001209191-19-025252","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-025252","line_url":"/filing/0001209191-19-025252#line-1","is_derivative":false,"issuer_cik":"0001406337","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001406337","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":22.32,"price_display":"22.32","price_state":"stated","total_value":107136.0,"total_display":"107,136.00","total_whole":"107,136","shares_owned_after":5500.0,"shares_owned_after_display":"5,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-16","filed_date":"2019-04-18","scope":"insider"},{"id":8877147,"accession":"0001104659-15-061011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-061011","line_url":"/filing/0001104659-15-061011#line-2","is_derivative":false,"issuer_cik":"0001406337","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001406337","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22694.0,"shares_display":"22,694","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":1588580.0,"total_display":"1,588,580.00","total_whole":"1,588,580","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-19","scope":"insider"},{"id":8940366,"accession":"0001104659-15-059173","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-059173","line_url":"/filing/0001104659-15-059173#line-2","is_derivative":false,"issuer_cik":"0001406337","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001406337","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2306.0,"shares_display":"2,306","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":161420.0,"total_display":"161,420.00","total_whole":"161,420","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-10","filed_date":"2015-08-12","scope":"insider"},{"id":8560383,"accession":"0001104659-15-050292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-050292","line_url":"/filing/0001104659-15-050292#line-2","is_derivative":false,"issuer_cik":"0001406337","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001406337","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":69.4763,"price_display":"69.48","price_state":"stated","total_value":1736907.5,"total_display":"1,736,907.50","total_whole":"1,736,908","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-06","filed_date":"2015-07-08","scope":"insider"},{"id":8199565,"accession":"0001104659-15-046745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-15-046745","line_url":"/filing/0001104659-15-046745#line-2","is_derivative":false,"issuer_cik":"0001406337","issuer_name":"Radius Health, Inc.","issuer_ticker":"RDUS","issuer_name_source":null,"issuer_url":"/issuer/0001406337","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":55.05,"price_display":"55.05","price_state":"stated","total_value":1376250.0,"total_display":"1,376,250.00","total_whole":"1,376,250","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-18","filed_date":"2015-06-22","scope":"insider"},{"id":5791583,"accession":"0000875320-09-000087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-09-000087","line_url":"/filing/0000875320-09-000087#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":34.7,"price_display":"34.70","price_state":"stated","total_value":52050.0,"total_display":"52,050.00","total_whole":"52,050","shares_owned_after":59880.0,"shares_owned_after_display":"59,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-10-19","filed_date":"2009-10-21","scope":"insider"},{"id":6029936,"accession":"0000875320-09-000068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-09-000068","line_url":"/filing/0000875320-09-000068#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3868.0,"shares_display":"3,868","price_per_share":33.47,"price_display":"33.47","price_state":"stated","total_value":129461.96,"total_display":"129,461.96","total_whole":"129,462","shares_owned_after":61380.0,"shares_owned_after_display":"61,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-20","filed_date":"2009-07-21","scope":"insider"},{"id":5676133,"accession":"0000875320-09-000033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-09-000033","line_url":"/filing/0000875320-09-000033#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":925.0,"shares_display":"925","price_per_share":28.44,"price_display":"28.44","price_state":"stated","total_value":26307.0,"total_display":"26,307.00","total_whole":"26,307","shares_owned_after":65248.0,"shares_owned_after_display":"65,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-18","filed_date":"2009-05-19","scope":"insider"},{"id":5771702,"accession":"0000875320-09-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-09-000022","line_url":"/filing/0000875320-09-000022#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2507.0,"shares_display":"2,507","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":80224.0,"total_display":"80,224.00","total_whole":"80,224","shares_owned_after":65248.0,"shares_owned_after_display":"65,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-28","filed_date":"2009-04-29","scope":"insider"},{"id":5851484,"accession":"0000875320-09-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-09-000021","line_url":"/filing/0000875320-09-000021","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":493.0,"shares_display":"493","price_per_share":26.984097363083166,"price_display":"26.98","price_state":"stated","total_value":13303.16,"total_display":"13,303.16","total_whole":"13,303","shares_owned_after":67965.0,"shares_owned_after_display":"67,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-21","filed_date":"2009-04-22","scope":"insider","n_lines":2},{"id":3516551,"accession":"0000875320-08-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-08-000086","line_url":"/filing/0000875320-08-000086#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379.0,"shares_display":"379","price_per_share":26.1,"price_display":"26.10","price_state":"stated","total_value":9891.9,"total_display":"9,891.90","total_whole":"9,892","shares_owned_after":56164.0,"shares_owned_after_display":"56,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-18","filed_date":"2008-11-19","scope":"insider"},{"id":3726887,"accession":"0000875320-08-000079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-08-000079","line_url":"/filing/0000875320-08-000079#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":485.0,"shares_display":"485","price_per_share":25.65,"price_display":"25.65","price_state":"stated","total_value":12440.25,"total_display":"12,440.25","total_whole":"12,440","shares_owned_after":56164.0,"shares_owned_after_display":"56,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-21","filed_date":"2008-10-22","scope":"insider"},{"id":3951905,"accession":"0000875320-08-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-08-000051","line_url":"/filing/0000875320-08-000051","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2925.0,"shares_display":"2,925","price_per_share":32.54179487179487,"price_display":"32.54","price_state":"stated","total_value":95184.75,"total_display":"95,184.75","total_whole":"95,185","shares_owned_after":56649.0,"shares_owned_after_display":"56,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-07-21","filed_date":"2008-07-23","scope":"insider","n_lines":2},{"id":2532947,"accession":"0000875320-08-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-08-000043","line_url":"/filing/0000875320-08-000043#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3549.0,"shares_display":"3,549","price_per_share":31.05,"price_display":"31.05","price_state":"stated","total_value":110196.45,"total_display":"110,196.45","total_whole":"110,196","shares_owned_after":59574.0,"shares_owned_after_display":"59,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-05","filed_date":"2008-06-09","scope":"insider"},{"id":3951903,"accession":"0000875320-08-000031","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000875320-08-000031","line_url":"/filing/0000875320-08-000031","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1512.0,"shares_display":"1,512","price_per_share":27.590958994708995,"price_display":"27.59","price_state":"stated","total_value":41717.53,"total_display":"41,717.53","total_whole":"41,718","shares_owned_after":63879.0,"shares_owned_after_display":"63,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-20","filed_date":"2008-05-22","scope":"insider","n_lines":9},{"id":3099484,"accession":"0000875320-08-000025","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000875320-08-000025","line_url":"/filing/0000875320-08-000025","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":951.0,"shares_display":"951","price_per_share":27.322376445846476,"price_display":"27.32","price_state":"stated","total_value":25983.58,"total_display":"25,983.58","total_whole":"25,984","shares_owned_after":63123.0,"shares_owned_after_display":"63,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-05-13","filed_date":"2008-05-15","scope":"insider","n_lines":8},{"id":7208856,"accession":"0000875320-07-000104","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000875320-07-000104","line_url":"/filing/0000875320-07-000104","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001406337","owner_name":"Graves Kurt","owner_display_name":"Graves Kurt","owner_url":"/insider/0001406337","role":"Officer (EVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3990.0,"shares_display":"3,990","price_per_share":25.14859649122807,"price_display":"25.15","price_state":"stated","total_value":100342.9,"total_display":"100,342.90","total_whole":"100,343","shares_owned_after":51200.0,"shares_owned_after_display":"51,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-06","filed_date":"2007-11-07","scope":"insider","n_lines":7}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":33,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001428522","name":"Radius Health, Inc.","url":"/issuer/0001428522","role":"Director","n_filings":5,"first_seen":"2015-06-22","last_seen":"2019-04-18"},{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP, Chief Commercial Officer)","n_filings":12,"first_seen":"2007-11-07","last_seen":"2009-10-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001406337","retrieved_at":"2026-08-22T18:40:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}